SCHEMBL15701281

SCHEMBL15701281

COc1ccc(C(=O)Nc2ccc3nc(NC(=O)c4cscn4)sc3c2)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.64
RAB9A P51151 6/20 0.64
POLB P06746 3/20 0.64
KDM4E B2RXH2 6/20 0.61
HTT P42858 3/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
RXFP1 Q9HBX9 5/20 0.60
ALDH1A1 P00352 4/20 0.60
KMT2A Q03164 7/20 0.56
MEN1 O00255 6/20 0.56
NTRK1 P04629 1/20 0.54
NPC1 O15118 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
HPGD P15428 3/20 0.52
TDP1 Q9NUW8 1/20 0.52
SCD O00767 5/20 0.51
LMNA P02545 2/20 0.51
THRB P10828 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
USP2 O75604 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15701242 0.86 SCD (0.68) MAPTRAB9APOLBKDM4EHTT
SCHEMBL15701287 0.86 LMNA (0.65) MAPTPOLBKDM4EALDH1A1KMT2A
SCHEMBL15701119 0.83 SCD (0.61) MAPTRAB9APOLBKDM4EHTT
SCHEMBL15701155 0.82 MEN1 (0.59) MAPTRAB9AKDM4EALDH1A1KMT2A
SCHEMBL15701084 0.81 CSNK1D (0.62) MAPTPOLBKDM4EKMT2AMEN1
SCHEMBL28826499 0.81 KDM4E (0.67) MAPTRAB9AKDM4EALDH1A1KMT2A
SCHEMBL15701100 0.80 NTRK1 (0.55) MAPTRAB9APOLBKDM4EHTT
SCHEMBL17148443 0.80 NTRK1 (0.53) MAPTRAB9APOLBKDM4EHTT
SCHEMBL15063066 0.80 KDM4E (0.73) MAPTRAB9APOLBKDM4EHTT
SCHEMBL15701288 0.79 HSD17B1 (0.48) MAPTRAB9APOLBKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334249-B2 Inhibitors of cytomegalovirus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-10 US disclosed
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-08 US disclosed
WO-2014070979-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS CDKN1A, CCNA1, IFNAR1 MAPT 2425/4885RAB9A 1015/4885POLB 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.